A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 28, 1995

Conditions
Cytomegalovirus RetinitisHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (22)

10016

New York Univ Med Ctr / Dept of Environmental Med, New York

10021

Cornell Univ Med Ctr, New York

20037

George Washington Univ Med Ctr, Washington D.C.

22203

Infectious Disease Physicians Inc, Annandale

48202

Henry Ford Hosp, Detroit

55455

Univ of Minnesota, Minneapolis

60611

Northwestern Univ Med School, Chicago

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

63110

Washington Univ Med Ctr, St Louis

64128

Kansas City Veterans Administration Med Ctr, Kansas City

77004

Plaza Med Ctr, Houston

77030

Infectious Diseases Association of Houston / Methodist Hosp, Houston

77550

Univ TX Galveston Med Branch, Galveston

87131

Univ of New Mexico Hlth Sciences Ctr / Dept of Med, Albuquerque

94115

Mount Zion Med Ctr, San Francisco

Stanford at Kaiser / Kaiser Permanente Med Ctr, San Francisco

94118

Pacific Presbyterian, San Francisco

94305

Stanford Univ School of Medicine, Stanford

94401

Mills Hosp, San Mateo

452670405

Holmes Hosp / Univ of Cincinnati Med Ctr, Cincinnati

462025250

Indiana Univ Hosp, Indianapolis

921036325

Univ of California / San Diego Treatment Ctr, San Diego

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000688 - A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS | Biotech Hunter | Biotech Hunter